Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624 in Irritable Bowel Syndrome
Sponsored by Procter and Gamble
About this trial
Last updated 14 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended 21 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Meet Rome II criteria for the diagnosis of IBS
- Refrain from using probiotic supplements during the trial
Exclusion Criteria
- Organic diseases, including inflammatory bowel disease, and significant systemic diseases
- Subjects over 55 years of age that had not had a sigmoidoscopy or colonoscopy performed in the previous five years
- Use of anti-psychotic medications within the prior three months
- Had major psychiatric disorder (DSM-II-R or DSM-IV), including major depression, psychoses, alcohol or substance abuse, within the past two years
- Were pregnant or nursing
- Had known lactose intolerance or immunodeficiency
- Had undergone any abdominal surgery, with the exception of hernia repair or appendectomy